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PPECIAL ARTICLE
re-Hospital 12-Lead Electrocardiography Programs
Call for Implementation by Emergency Medical Services
ystems Providing Advanced Life Support—National Heart
ttack Alert Program (NHAAP) Coordinating Committee; National
eart, Lung, and Blood Institute (NHLBI); National Institutes of Health
. Lee Garvey, MD,* Bruce A. MacLeod, MD, FACEP,† George Sopko, MD,‡
ary M. Hand, MSPH, RN,‡ on behalf of the National Heart Attack Alert Program (NHAAP)
oordinating Committee
harlotte, North Carolina; Pittsburgh, Pennsylvania; and Bethesda, Maryland
Emergency medical services (EMS) providers who administer advanced life support should
include diagnostic 12-lead electrocardiography programs as one of their services. Evidence
demonstrates that this technology can be readily used by EMS providers to identify patients
with ST-segment elevation myocardial infarction (STEMI) before a patient’s arrival at a
hospital emergency department. Earlier identification of STEMI patients leads to faster
artery-opening treatment with fibrinolytic agents, either in the pre-hospital setting or at the
hospital. Alternatively, a reperfusion strategy using percutaneous coronary intervention can be
facilitated by use of pre-hospital 12-lead electrocardiography (P12ECG). Analysis of the cost
of providing this service to the community must include consideration of the demonstrated
benefits of more rapid treatment of patients with STEMI and the resulting time savings
advantage shown to accompany the use of P12ECG programs. (J Am Coll Cardiol 2006;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.07247:485–91) © 2006 by the American College of Cardiology Foundation
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ooronary heart disease, the single largest cause of death in
.S. men and women, was responsible for more than one in
very five deaths in 2002. According to the latest estimates,
s many as 1.2 million Americans experience an acute
yocardial infarction (AMI) each year, resulting in over
94,300 deaths (1).
A decade has passed since a working group of the
ational Heart Attack Alert Program (NHAAP) published
60 Minutes to Treatment,” a position paper on rapid
dentification and treatment of patients with AMI (2). This
tatement challenged the U.S. health care system to provide
efinitive artery-opening (reperfusion) treatment (notably
From the *Carolinas Medical Center, Charlotte, North Carolina; †Mercy Hospital
f Pittsburgh, Pittsburgh, Pennsylvania; and the ‡National Heart, Lung, and Blood
nstitute, Bethesda, Maryland. The following NHAAP Coordinating Committee
rganizations have approved this position paper: Agency for Healthcare Research and
uality; American Academy of Insurance Medicine; American Academy of Physician
ssistants; American Heart Association; American Association for Clinical Chem-
stry, Inc.; American Association of Critical Care Nurses; American Association of
ccupational Health Nurses, Inc.; American College of Cardiology; American
ollege of Chest Physicians; American College of Emergency Physicians; American
ollege of Occupational and Environmental Medicine; American College of Physi-
ians; American College of Preventive Medicine; American Medical Association;
merican Pharmacists Association; American Public Health Association; American
ed Cross; Association of Black Cardiologists; Centers for Disease Control and
revention; Centers for Medicare and Medicaid Services; Emergency Nurses Asso-
iation; Food and Drug Administration; Health Resources and Services Administra-
ion; Heart Rhythm Society; International Association of Fire Chiefs; International
ssociation of Fire Fighters; National Association of Emergency Medical Techni-
ians; National Association of EMS Physicians; National Association of State EMS
irectors; National Black Nurses Association; National Medical Association; Societyw
f Chest Pain Centers; Society of General Internal Medicine.
Manuscript received August 4, 2005, accepted August 23, 2005.brinolytic) to eligible AMI patients within 60 min of
ymptom onset, and within 30 min of arrival at the hospital.
hese benchmarks are critical because the benefits of AMI
reatment diminish rapidly over time (3). Early reperfusion
reatment for eligible AMI patients has a significant impact
n morbidity and mortality (4). The benefit of a shorter
ime to artery-opening treatment with fibrinolytics and
ercutaneous coronary intervention (PCI) has been conclu-
ively shown for patients with ST-segment elevation myo-
ardial infarction (STEMI) (4–7). For fibrinolytic therapy,
he beneficial effects are substantially greater in patients
reated early after symptom onset than in those treated later,
nd mortality reduction is greatest among patients present-
ng to the hospital within 1 h of symptom onset. The benefit
f fibrinolytic therapy initiated within 30 to 60 min after the
nset of symptoms is estimated to result in 60 to 80
dditional patients alive, at one month, per 1,000 patients
reated with conventional therapy (8). These data support
he well-known concept of a “golden hour” for AMI. The
mportance of total ischemic time has also been described for
rtery-opening treatment by PCI (6,9–11). The length of time
rom symptom onset to balloon inflation has been shown to be
ignificantly correlated with one-year mortality (6). While PCI
onfers a higher rate of reperfusion, notably in patients pre-
enting later in the course of infarction, myocardial necrosis is
elated to the duration of occlusion of the infarct-related artery,
articularly in patients at greater risk (6). Thus, the time to
pening of the infarct-related artery is important for patients
ho receive PCI as well as fibrinolysis (12).
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Pre-Hospital 12-Lead ECG Programs February 7, 2006:485–91The use of measurable time intervals (e.g., from arrival at
he emergency department [ED] [“door”] to the initial
lectrocardiogram [“data”], and from the decision to treat
“decision”] to fibrinolytic drug administration time
“drug”]) has been promoted as a means for individual
ospitals to study their system of care, implement changes
n their processes, and improve performance relative to these
enchmarks (2). Many hospitals can now state that defini-
ive care is provided to STEMI patients within the bench-
ark time interval starting with arrival at the ED, but the
roportion of patients treated within 60 min of symptom
nset is only 4% for fibrinolytics and less than 1% for PCI
E. Stoehr, National Registry of Myocardial Infarction,
ersonal communication, July 2004). Given the previously
ublished time-to-treatment goals and the increased avail-
bility of PCI as an option for these patients, the American
ollege of Cardiology (ACC) and the American Heart
ssociation (AHA) recommend that after eligible STEMI
atients present to the “medical system” (either emergency
edical services [EMS] or the ED), they should receive
brinolytic therapy within 30 min or PCI within 90 min (13).
For these benchmarks to be met, emphasis on further
mprovements in the time to definitive care for patients with
TEMI must look to pre-hospital factors. Patient and
ystander delays are responsible for the greatest proportion
f delay before treatment (14). Major clinical trials show
hat the median time from symptom onset to treatment of
ersons with STEMI is approximately 2 to 3 h (15–17).
atient-related delay in seeking treatment has remained
argely unchanged over the last decade, even though studies
ave shown that the effectiveness of reperfusion therapy
epends on timely intervention (16,18–20). The full poten-
ial of current artery-opening treatments has not been
ealized because many patients are not seen in the hospital
n time to fully reap their benefits (18,21).
Patients’ recognition of symptoms, their motivation to
eek care very early in the course of symptoms, and their use
f EMS to provide immediate care will ultimately increase
Abbreviations and Acronyms
ACC  American College of Cardiology
ACI-TIPI  acute cardiac ischemia time-insensitive
predictive instrument
ACS  acute coronary syndromes
AHA  American Heart Association
AHRQ  Agency for Healthcare Research and
Quality
ALS  advanced life support
AMI  acute myocardial infarction
ED  emergency department
EMS  emergency medical services
EMT-P  emergency medical technician-paramedic
PCI  percutaneous coronary intervention
P12ECG  pre-hospital 12-lead electrocardiography
STEMI  ST-segment elevation myocardial infarctionhe number of persons receiving care within 60 min of (ymptom onset (22). Two educational initiatives, the Na-
ional Heart, Lung, and Blood Institute’s “Act in Time to
eart Attack Signs,” campaign (23,24) and the Society of
hest Pain Centers’ “Early Heart Attack Care” program
25,26), target educating potential patients (and others who
ay be in a position to help patients act quickly) to
ecognize and respond to symptoms associated with acute
oronary syndromes (ACS). Community intervention and
ducational campaigns may promote the appropriate use of
MS by potential AMI patients (27).
The use of EMS in itself has been shown to be associated
ith earlier evaluation in the ED, wider use of acute
eperfusion therapies, and less time between arrival at the
D, to fibrinolytic therapy or urgent PCI (17,28–32). Even
hough use of EMS is associated with earlier evaluation and
reatment in the hospital setting, only 10% to 59% of
atients with chest pain use such services for treatment and
ransportation to the hospital (17,29,30,33,34). Most pa-
ients are driven by someone else (about 60%) or drive
hemselves to the hospital (nearly 16%) (29,33). Emergency
edical services is the only means by which patients can
btain the earlier evaluation and treatment benefit associ-
ted with pre-hospital 12-lead electrocardiography
P12ECG).
Pre-hospital electrocardiographs are usually sold as addi-
ional modular components or integrated into monitor-
efibrillator devices. Pre-hospital 12-lead electrocardiography
ntails application of recording electrodes, capture of electro-
ardiographic data, automated interpretation using diagnostic
lgorithms within the device, transmission capability, and the
ption for over-read of the output by paramedics. The
uality of P12ECG data has been shown to be equal to that
btained in the hospital (35,36). Pre-hospital 12-lead elec-
rocardiographic data are readily obtained at the point of
are of the patient in the pre-hospital environment, without
ndue delay in transportation to the hospital (35,37–39).
lthough a longer time from symptom onset to hospital
resentation for the P12ECG group was reported in one
eries (40), the time to in-hospital reperfusion was signifi-
antly less in the P12ECG group. Printable copies of
12ECG data can be sent to hospital EDs via cellular
elephone, or direct medical oversight physicians can discuss
he paramedic’s interpretation and other relevant aspects of
he patient’s symptoms, risk profile, and response to initial
herapy. While many EMS providers are trained in the
nterpretation of 12-lead electrocardiography, and comput-
rized algorithms provide diagnostic statements that para-
edics can over-read, it is also possible to receive real-time
emote interpretation of pre-hospital 12-lead electrocardio-
rams by expert physician electrocardiographers (41). The
re-hospital 12-lead electrocardiogram should be expedi-
iously over-read by a qualified physician.
enefits of a P12ECG. The pre-hospital 12-lead electro-
ardiogram has favorable diagnostic and clinical impact
atings. The Agency for Healthcare Research and Quality
AHRQ) included P12ECG in its assessment of a wide
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February 7, 2006:485–91 Pre-Hospital 12-Lead ECG Programsange of technologies used for identification of patients with
cute cardiac ischemia in EDs (42,43). The AHRQ review
ound P12ECG to be moderately sensitive (76%) and
pecific (88%) for the diagnosis of ACS (36,44–48), and
8% sensitive and 97% specific for the diagnosis of AMI
36,44–47,49–54). The same report (42) found that the
cute cardiac ischemia time-insensitive predictive instru-
ent (ACI-TIPI), which prints the patient’s probability of
aving ACS on the electrocardiogram header, improved the
iagnosis of ACS. Further research is needed to test the
otential impact of ACI-TIPI on EMS-based identification
f ACS (55).
Pre-hospital 12-lead electrocardiography acquisition has
een shown to be feasible and to result in earlier identifi-
ation of patients with STEMI (39,56–59). Pre-hospital
2-lead electrocardiography has been shown to reduce the
edian time to fibrinolytic therapy in the hospital by 32 to
2 min (58,60,61). According to a study that examined a
arge registry of STEMI patients, activation of the cardiac
atheterization laboratory using P12ECG data was shown
o reduce the mean time to PCI by an average of 23 min (92
s. 115 min, p  0.001) (40). The P12ECG group was
ore likely to receive fibrinolytic therapy (43% vs. 37%, p
.001) and to undergo PCI (11% vs. 7%, p  0.001). Also,
he P12ECG group was more likely to undergo coronary
rteriography (55% vs. 40%, p  0.001), angioplasty (24%
s. 16%, p  0.001), or bypass surgery (10% vs. 6%, p 
.001). The influence of other factors in addition to
12ECG was not completely controlled for in this report,
ut the authors emphasized the importance of P12ECG in
ffecting wider, faster utilization of reperfusion strategies,
reater usage of invasive procedures, and lower in-hospital
ortality (8% vs. 12%, p  0.001) for STEMI patients who
eceived P12ECG versus those who did not (40).
One study of the use of P12ECG by paramedics (53)
emonstrated a nonsignificant trend toward lower all-cause
ortality among the P12ECG patients directly admitted for
reatment to the hospital coronary care unit (p 0.22). This
as in addition to the main findings of 1 h reductions in
oth the EMS-call-to-fibrinolysis interval, and the door-to-
rug interval, for the patients with P12ECG and direct
oronary care unit admission by paramedics.
The clinical impact associated with use of P12ECG has
een largely addressed by comparing the initiation of
re-hospital fibrinolysis, with hospital initiation of fibrino-
ysis (42,43). The outcomes of these randomized trials and
rospective, nonrandomized studies have been reported in
erms of time savings, early differences in left ventricular
unction, hospital mortality, and long-term mortality
42,43). In these studies where P12ECG was used in
onjunction with a pre-hospital fibrinolysis program, it is
ot possible to attribute clinical impact effects associated
olely with P12ECG versus that of pre-hospital fibrinolysis.
re-hospital fibrinolysis alone has been shown in a meta-
nalysis to significantly decrease the time to fibrinolysis and
ll-cause hospital mortality (62). Pooled results of six wandomized trials (n  6,434 patients) showed a signifi-
antly decreased all-cause hospital mortality among patients
reated with pre-hospital fibrinolysis compared with hospi-
al fibrinolysis (odds ratio, 0.83; 95% confidence interval,
.70 to 0.98). The estimated time from symptom onset to
brinolysis was 104 min for the pre-hospital group and 162
in for the in-hospital fibrinolysis group (62). The Myocar-
ial Infarction Triage and Intervention trial (61) did not find a
re-hospital fibrinolytic strategy superior to a hospital-based
trategy, but did demonstrate the overriding benefit of early
eperfusion with fibrinolytics for patients in either group
ho were treated within 70 min. Advance notification of
he hospitals of a STEMI patient resulted in expedited care
nce the patient arrived, compared to the usual ED care the
atient would have received without the advance notifica-
ion afforded by P12ECG.
MPLEMENTING AN EFFECTIVE P12ECG PROGRAM
espite reports of the utility of P12ECG, particularly its
ffectiveness in reducing time intervals to treatment and a
rend toward lower short-term mortality of STEMI pa-
ients, this strategy has been incompletely adopted by EMS
gencies in the U.S. According to a survey that collected
ata on EMS systems in 200 U.S. cities (63), 67% of those
ystems had P12ECG as part of their available equipment
nd procedure capability (the average total population
erved by the survey respondents was 459,804; the average
eographic coverage area was 294 square miles). Less
opulous cities and rural regions may have even fewer
ystems incorporating P12ECG. Nationally standardized
ata on the actual use of P12ECG by these systems are
navailable.
Because of the advantage gained by P12ECG with
dvance ED notification in rapid diagnosis and treatment of
CS, in particular, STEMI, the ACC/AHA recommend
hat “It is reasonable that all advanced cardiac life support
roviders perform and evaluate 12-lead ECGs routinely on
hest pain patients suspected of STEMI (level of evidence
, based on data from a number of nonrandomized studies)”
13). Pre-hospital 12-lead electrocardiography programs
mploying urban and suburban paramedics have previously
een strongly encouraged by the AHA (64), the ACC (65),
he National Association of EMS Physicians (66), as well as
he ACC/AHA Guidelines for Management of Patients
ith ST-Elevation Myocardial Infarction (13). See Table 1
or a description of the benefits of P12ECG for AMI
atients and EMS providers (67,68).
Barriers to the implementation of P12ECG programs
nclude the costs of device acquisition and replacement,
aramedic training, and ongoing competency assessment.
ntegrated devices (pre-hospital 12-lead electrocardiograph
ith monitor-defibrillator) now cost $9,000 to $25,000
ach, but the expense of the equipment is likely to decrease
n the future as it becomes more standard (as has occurred
ith automated external defibrillators, for example). Re-
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Pre-Hospital 12-Lead ECG Programs February 7, 2006:485–91lacement or upgrade costs of current integrated devices
ay be less. A formal cost effectiveness of P12ECG has not
een published (69).
Advanced life support (ALS) providers are the focus of
his paper because these individuals are trained and
quipped to identify and manage patients with ACS symp-
oms and, as such, are essential to the implementation of
12ECG programs. The EMS Agenda for the Future (70)
alls for EMS to work with national organizations and
ssociations to help determine its role in enhancing identi-
cation and treatment of various clinical conditions (e.g.,
yocardial infarction). The agenda advocates that EMS
linical care be subjected to ongoing evaluation to determine
ts impact on patient outcomes and that changes in clinical
are should be justifiable based on community health care
eeds.
Paramedic education in electrocardiography is currently a
omponent of 1998 Emergency Medical Technician-
aramedic (EMT-P): National Standard Curriculum by the
ational Highway Traffic Safety Administration (71), but it
s considered “enhanced” rather than “core” education con-
ent. Those EMT-P professionals requiring specific training
n P12ECG typically undergo up to 12 h of classroom and
ractical training. Competency assessments are routine
omponents of the administration of EMS agencies, and
nclusion of P12ECG for proficiency testing should not
ignificantly increase this cost. The P12ECG program
hould be implemented with qualified medical oversight.
Implementing a P12ECG program represents a signifi-
ant investment of time, effort, personnel, and resources.
mplementation has three phases: phase I is a retrospective
able 1. Benefits of Pre-Hospital 12-Lead Electrocardiography
rograms
or AMI patients
Earlier evaluation in the field and in the hospital
Earlier treatment with fibrinolysis and PCI
Triage in the field, sending high-risk patients to tertiary hospitals
Improved outcomes in terms of:
Reduction in short-term mortality
Longer-term survival benefit (reported in some studies but not all)
or EMS providers
Enhanced skill acquisition in pre-hospital electrocardiography and
opportunities to use that technology
Improved pre-hospital detection accuracy in chest pain patients
Detection of transient pre-hospital ischemia that may be resolved by
the time of hospital arrival
Acquisition of a 12-lead electrocardiogram for comparison with the
first ED electrocardiogram
Potential to differentiate more accurately pre-hospital cardiac
arrhythmias (e.g., wide complex tachycardias)
Advance notice of STEMI patient en route for ED staff and cardiac
catheterization team
Potentially improved process of care and treatment measures
monitored by quality improvement organizations
odified from Aufderheide et al. (67) and Urban et al. (68).
AMI  acute myocardial infarction; ED  emergency department; EMS 
mergency medical services; PCI  percutaneous coronary intervention; STEMI 
T-segment elevation myocardial infarction.aseline analysis; phase II, a feasibility and safety assess- pent; and phase III, the implementation of accurate and
outine pre-hospital identification of fibrinolytic or PCI
andidates to facilitate hospital-based definitive therapy
67,72). Pre-hospital 12-lead electrocardiography and ad-
ance ED notification may utilize verbal notification or
ransmission of the electrocardiogram. In the latter form of
otification, it is important to ensure that transmitted
lectrocardiograms are identified with the appropriate pa-
ient; P12ECG identification forms can facilitate this goal.
ibrinolytic and PCI eligibility can be determined by means
f a paramedic-generated checklist, the results of which can
hen be conveyed to either the base or receiving physician.
embers of the medical community should be educated
bout the P12ECG program and how to effectively use the
dvance notification of diagnostic information to deliver
ore time-effective interventions. A written protocol, in-
luding clinical algorithms for pre-hospital personnel,
hould be established (67,72). Finally, an effective quality
ssurance and improvement program should be initiated in
dvance of implementing a P12ECG program, and is
undamental to P12ECG implementation and ongoing
valuation. Pre-hospital 12-lead electrocardiography with
dvance ED notification has the greatest potential for
atient benefit when the information is utilized as a key
omponent of significant patient care improvements
hrough a well-planned and coordinated program
67,72,73). When considering implementation of a
12ECG program, EMS system administrators need to
dentify and inform key participants, address political issues,
nd find alternative sources of funding to cover costs, both
irect (e.g., equipment, training, supplies) and indirect (e.g.,
ospital, EMS system, program infrastructure, and organi-
ation). People who will be involved in program coordina-
ion, training and competency evaluation, and communica-
ion mechanisms should be identified along with those
nvolved in program implementation. Pre-hospital 12-lead
lectrocardiogram programs should be strongly considered
y all EMS systems with ALS capability. Ultimately, the
ecision to implement a P12ECG program in a community
hould be based on an evaluation of resources available and
ublic health priorities. Pre-hospital 12-lead electrocardio-
ram programs should be implemented through a system-
tic process that encompasses all facets of the EMS system
nd under the supervision of the EMS physician medical
irector (74).
The ACC/AHA (13) has specified the conditions under
hich a pre-hospital fibrinolysis program is reasonable: 1)
hen physicians are present in the ambulance; or 2) in
ell-organized EMS systems with full-time paramedics
apable of acquiring pre-hospital 12-lead electrocardio-
rams and interpreting or reading software through initial
nd ongoing training in P12ECG interpretation and myo-
ardial infarction treatment, direct medical oversight, a
edical director with training/experience in STEMI man-
gement, and an ongoing continuous quality improvement
rogram. However, the strategy of P12ECG alone (without
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February 7, 2006:485–91 Pre-Hospital 12-Lead ECG Programsmmediate fibrinolytic therapy) is a simpler approach and
as established benefits (67). This approach may be further
ugmented by use of pre-hospital electrocardiographs that
ave the thrombolytic predictive instrument, although pro-
pective validation of its benefits in the out-of-hospital
etting remains untested (75).
Creation of local or regional cardiac destination hospitals,
acilities capable of cardiac catheterization and rapid revas-
ularization has been proposed as a means for improving
utcomes for patients with STEMI (76–78). Availability of
re-hospital electrocardiography is intrinsic to this proposal.
urrent guidelines (13) recommend that STEMI patients
ith cardiogenic shock, or with contraindications to fibrino-
ytic therapy, should be brought immediately to facilities
apable of cardiac catheterization and rapid revasculariza-
ion with PCI or coronary artery bypass grafting (13).
iscussions about regionalization should not eclipse the
ssue of a continued shortfall in care of the 30% of eligible
TEMI patients who do not receive any reperfusion therapy
79,80). Pre-hospital 12-lead electrocardiography, with ad-
ance notice of STEMI patients en route to an ED, can
ptimally be used to prompt action before the patient’s
rrival. A variety of strategies have been employed, all with
he goal of rapidly instituting therapy to reestablish perfu-
ion of the culprit infarct-related artery. Activation of a
ardiac response team will have care providers and medical
ecision makers ready for the arrival of a STEMI patient.
dditional hospital-based resources (e.g., nursing, radiol-
gy) acting as a team can rapidly accomplish tasks according
o a prearranged design (81). Decisions about a patient’s
reatment and disposition can be made quickly.
In summary, use of P12ECG with advance ED notifica-
ion in patients with symptoms suggestive of ACS will allow
greater number of STEMI patients to receive definitive
are more quickly. Pre-hospital 12-lead electrocardiography
ith advance notification has the greatest potential for
hortening the time to definitive treatment when the infor-
ation is utilized as a key component of a well-planned and
oordinated program. Use of this technology is supported by
vidence suggesting improved treatment outcomes, but
12ECG programs are underutilized in the U.S. The
ational Heart, Lung, and Blood Institute’s National Heart
ttack Alert Program Coordinating Committee believes
he collective evidence demonstrating benefit of this ap-
roach supports implementation of P12ECG programs in
LS systems.
eprint requests and correspondence: Mary Hand, MSPH, RN,
/o NHLBI Information Center, P.O. Box 30105, Bethesda,
aryland 20824. E-mail: NHLBIinfo@nhlbi.nih.gov.
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